Literature DB >> 32570396

Machine Learning Explainability in Breast Cancer Survival.

Tom Jansen1,2, Gijs Geleijnse2, Marissa Van Maaren2,3, Mathijs P Hendriks2,4, Annette Ten Teije1, Arturo Moncada-Torres2.   

Abstract

Machine Learning (ML) can improve the diagnosis, treatment decisions, and understanding of cancer. However, the low explainability of how "black box" ML methods produce their output hinders their clinical adoption. In this paper, we used data from the Netherlands Cancer Registry to generate a ML-based model to predict 10-year overall survival of breast cancer patients. Then, we used Local Interpretable Model-Agnostic Explanations (LIME) and SHapley Additive exPlanations (SHAP) to interpret the model's predictions. We found that, overall, LIME and SHAP tend to be consistent when explaining the contribution of different features. Nevertheless, the feature ranges where they have a mismatch can also be of interest, since they can help us identifying "turning points" where features go from favoring survived to favoring deceased (or vice versa). Explainability techniques can pave the way for better acceptance of ML techniques. However, their evaluation and translation to real-life scenarios need to be researched further.

Entities:  

Keywords:  Artificial Intelligence; interpretability; oncology; prediction model

Year:  2020        PMID: 32570396     DOI: 10.3233/SHTI200172

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  2 in total

1.  Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival.

Authors:  Arturo Moncada-Torres; Marissa C van Maaren; Mathijs P Hendriks; Sabine Siesling; Gijs Geleijnse
Journal:  Sci Rep       Date:  2021-03-26       Impact factor: 4.379

2.  Integrating Clinical Data and Attentional CT Imaging Features for Esophageal Fistula Prediction in Esophageal Cancer.

Authors:  Yiyue Xu; Hui Cui; Taotao Dong; Bing Zou; Bingjie Fan; Wanlong Li; Shijiang Wang; Xindong Sun; Jinming Yu; Linlin Wang
Journal:  Front Oncol       Date:  2021-11-23       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.